Kubota Vision Announced End of Phase 3 Clinical Trial of Emixustat in Patients with Stargardt Disease

2 years ago

SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (�Kubota Vision�), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo…

Enteral Nutrition Market Research Report 2022: Growing at a CAGR of 9.62% to $8.6+ Billion by 2027 – ResearchAndMarkets.com

2 years ago

DUBLIN--(BUSINESS WIRE)--The "Enteral Nutrition Market Research Report by Product (Nutrition for Chronic Illness and Standard Formula), Application, End User, Distribution…

Japan Travel Insurance Market 2022-2027 With Ansoff Analysis – ResearchAndMarkets.com

2 years ago

DUBLIN--(BUSINESS WIRE)--The "Japan Travel Insurance Market (2022-2027) by Type, Distribution, End-User, Competitive Analysis and the Impact of Covid-19 with Ansoff…

Hytera Honored with International Critical Communications Awards at CCW 2022

2 years ago

VIENNA--(BUSINESS WIRE)--#CommunicationSolutions--Hytera is proud to announce that its Hytera HyTalk MC Solution for Sri Lanka Railway (SLR) won the Best…

Global E-Pharmacy Market Size & Share to 2027 – Featuring Pharmacy2U, Gordons Direct and MedPlus Health Services Among Others – ResearchAndMarkets.com

2 years ago

DUBLIN--(BUSINESS WIRE)--The "Global E-Pharmacy Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering. E-pharmacy is referred…

AM Best Affirms Credit Ratings of Dhipaya Insurance Public Company Limited

2 years ago

SINGAPORE--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of �a-�…

Hytera at CCW 2022 Is Showcasing Convergence-Native Solutions for Critical Communications Sector

2 years ago

VIENNA--(BUSINESS WIRE)--#5G--Critical Communications Week (CCW) took place in Vienna, Austria on 21st June, 2022. The event has been running for…

Best Mart 360 Holdings Limited Announces FY2021/22 Annual Results; Core Net profit Surged Significantly by 121.0% YoY; Proposed a final dividend of HK$8.0 cents per share

2 years ago

Highlights: Revenue increased by 21.8% to approximately HK$1,983.5million. Gross profit increased by 28.4% to approximately HK$667.7 million. Operating profit increased…

Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA� ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

2 years ago

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of…

Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma

2 years ago

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Acquisition--Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with…